Source: Eur Respir J 2011; 37: 1308-1417



Rating:

Share or cite this content

Citations should be made in the following way:
Laube B.L., Janssens H.M., de Jongh F.H.C., Devadason S.G., Dhand R., Diot P., Everard M.L., Horvath I., Navalesi P., Voshaar T., Chrystyn H.. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 37: 1308-1417

Member's Comments

No comment yet.

Related content which might interest you: What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1054-1055 Year: 2012 What the pulmonary specialist should know about the new inhalation therapies Source: Guideline 2011 Year: 2011 What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2012; 39: 1055-1056 Year: 2012 Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Year: 2007 Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation Source: Eur Respir J 2011; 38: 1328-1335 Year: 2011 Distribution of technetium-99m-labelled QVARTM delivered using an AutohalerTM device in children Source: Eur Respir J 2003; 21: 1007-1011 Year: 2003 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 Selection of the optimal nebulizer for further clinical development of inhaled nebulized nitrite (AIR001) in pulmonary arterial hypertension patients Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 When to give corticosteroid inhalation therapy in stable COPD Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001 Reproducibility of inhaler use and pulmonary drug deposition in COPD Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Is there room for further innovation in inhaled therapy for airways disease? Source: Breathe, 14 (3) 216; 10.1183/20734735.020318 Year: 2018 Modern treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 60S-66S Year: 2001 The influence of type of inhalation device on adherence of COPD patients to inhaled medication Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Inhaled iloprost for the treatment of pulmonary hypertension Source: Eur Respir Rev 2009; 18: 29-34 Year: 2009 High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003